When bioprosthetic cardiac valves fail, reoperative valve replacement carries a higher risk of
morbidity and mortality compared with initial valve replacement. Transcatheter heart valve …

Surgical aortic valve replacement (SAVR) is currently the standard of care to treat patients
with severe symptomatic aortic stenosis (AS) and is generally accepted to alleviate …

Background—Transcatheter aortic valve-in-valve implantation is an emerging therapeutic
alternative for patients with a failed surgical bioprosthesis and may obviate the need for …

Bioprosthetic valves are increasingly used in patients with aortic stenosis. Compared with
mechanical valves, bioprosthetic valves are associated with a lower risk of thromboembolic …

Until recently, heart valve failure has been treated adopting open-heart surgical techniques
and cardiopulmonary bypass. However, over the last decade, minimally invasive procedures …

Transcatheter aortic valves (TAVs) represent the latest advances in prosthetic heart valve
technology. TAVs are truly transformational as they bring the benefit of heart valve …

Transcatheter aortic valve implantation (TAVI) enables treatment of aortic stenosis with no
need for open heart surgery. According to current guidelines, only patients considered at …

Transcatheter aortic valve replacement (TAVR) is an established treatment alternative to
surgical valve replacement in high-risk patients with severe symptomatic aortic stenosis. The …

Abstract Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) has been
established as a safe and effective means of treating failed surgical bioprosthetic valves …

Implants, including artificial joints, bone fixation devices, and other orthopedic implants, oral
implants, and vascular interventional devices, are used to repair or replace human tissues or …